Clinical Characteristics of the First 100 Patients of COVID-19 in Tobruk, Libya: A Brief Report From Low-Resource Settings.

COVID-19 Libya SARS-CoV-2 chest X-ray laboratory findings rapid test antibodies

Journal

Disaster medicine and public health preparedness
ISSN: 1938-744X
Titre abrégé: Disaster Med Public Health Prep
Pays: United States
ID NLM: 101297401

Informations de publication

Date de publication:
19 Apr 2021
Historique:
pubmed: 20 4 2021
medline: 20 4 2021
entrez: 19 4 2021
Statut: aheadofprint

Résumé

This study aims to report the clinical features of a cohort of patients with suspected coronavirus disease (COVID-19) from Tobruk, Libya, and reflect upon the diagnosis challenge in low-resource settings. A descriptive report of the first 100 patients with suspected COVID-19 who have visited the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 screening clinic at the National Centre for Disease Control in Tobruk, Libya. The most common presenting symptoms were fever (90%), cough (89%), dyspnea (85%), sore throat (79%), fatigue (78%), headache (64%), loss of smell (52%), loss of taste (53%), loss of appetite (43%), nausea and vomiting (26%), diarrhea (22%), and rhinorrhea (16%); 51% of the patients had lymphocytopenia, whereas 13% had thrombocytopenia. Bilateral infiltrates were the most common radiologic finding on chest X-ray (76%), and COVID-19 IgM and/or IgG antibodies were detected in 80% of the patients, whereas only 37% of the patients were tested positive by the reverse transcriptase polymerase chain reaction (RT-PCR). The disease continued its spread across the region. Fever, cough, and dyspnea were the main symptoms; 21% of the patients did not have any chest X-ray abnormalities. Initial negative results for either antibody testing or RT-PCR-testing for COVID-19 do not rule out the infection.

Identifiants

pubmed: 33867007
pii: S1935789321001233
doi: 10.1017/dmp.2021.123
pmc: PMC8193191
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Références

Radiology. 2020 Aug;296(2):E72-E78
pubmed: 32216717
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Clin Med. 2020 May 18;9(5):
pubmed: 32443459
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
PLoS One. 2020 Aug 21;15(8):e0238160
pubmed: 32822430
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
JAMA. 2020 Jun 9;323(22):2249-2251
pubmed: 32374370
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510

Auteurs

Faisal Ismail (F)

Clinical Laboratory Department, Faculty of Medical Technology, University of Tobruk, Tobruk, Libya.
National Centre for Disease Control, Tobruk, Libya.

Atiya Farag (A)

National Centre for Disease Control, Tobruk, Libya.

Soghra Haq (S)

Clinical Laboratory Department, Faculty of Medical Technology, University of Tobruk, Tobruk, Libya.

Mohammad A Kamal (MA)

West China School of Nursing/Institutes for Systems Genetics, Frontiers Science Centre for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia.
Enzymoics, Novel Global Community Educational Foundation, Australia.

Classifications MeSH